BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1
319 results:

  • 1. Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United States.
    Jonasch E; Song Y; Freimark J; Berman R; Nguyen H; Signorovitch J; Sundaram M
    Orphanet J Rare Dis; 2024 Feb; 19(1):73. PubMed ID: 38365728
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. vhl suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation.
    Wang Z; Yan M; Ye L; Zhou Q; Duan Y; Jiang H; Wang L; Ouyang Y; Zhang H; Shen Y; Ji G; Chen X; Tian Q; Xiao L; Wu Q; Meng Y; Liu G; Ma L; Lei B; Lu Z; Xu D
    EMBO J; 2024 Mar; 43(6):931-955. PubMed ID: 38360997
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A case report of cerebellar hemangioblastoma simulated brain metastasis shown by magnetic resonance imaging.
    Xue J; Mo C
    Medicine (Baltimore); 2024 Feb; 103(6):e37162. PubMed ID: 38335432
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinico-pathologic profile and outcomes of pediatric endocrine patients managed by endocrine surgeons: Experience over three decades in a tertiary center in India.
    Vikram S; Mishra A; Bhatia V; Mayilvagnan S; Chand G; Agarwal G; Agarwal A; Dabadghao P; Mishra SK
    World J Surg; 2024 Mar; 48(3):729-738. PubMed ID: 38299448
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Multiple neuroendocrine tumors of the pancreas].
    Sipos B
    Pathologie (Heidelb); 2024 Feb; 45(1):28-34. PubMed ID: 38180510
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. EUS-guided fine needle aspiration-based clues to mistaken or uncertain identity: serous pancreatic cysts.
    Yip-Schneider MT; Muraru R; Kim RC; Wu HH; Sherman S; Gutta A; Al-Haddad MA; Dewitt JM; Schmidt CM
    HPB (Oxford); 2023 Dec; 25(12):1587-1594. PubMed ID: 37749004
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Promising targetable biomarkers in pancreatic neuroendocrine tumours.
    Borghesani M; Gervaso L; Cella CA; Benini L; Ciardiello D; Algeri L; Ferrero A; Valenza C; Guidi L; Zampino MG; Spada F; Fazio N
    Expert Rev Endocrinol Metab; 2023; 18(5):387-398. PubMed ID: 37743651
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Population pharmacokinetic analyses for belzutifan to inform dosing considerations and labeling.
    Marathe DD; Jauslin PM; Kleijn HJ; de Miranda Silva C; Chain A; Bateman T; Shaw PM; Abraham AK; Kauh EA; Liu Y; Perini RF; de Alwis DP; Jain L
    CPT Pharmacometrics Syst Pharmacol; 2023 Oct; 12(10):1499-1510. PubMed ID: 37596839
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Selective HIF2A Inhibitors in the Management of Clear Cell Renal cancer and Von Hippel-Lindau-Disease-Associated Tumors.
    Suárez C; Vieito M; Valdivia A; González M; Carles J
    Med Sci (Basel); 2023 Jun; 11(3):. PubMed ID: 37489462
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hemangioblastomas and Other Vascular Origating Tumors of Brain or Spinal Cord.
    Vetrano IG; Gioppo A; Faragò G; Pinzi V; Pollo B; Broggi M; Schiariti M; Ferroli P; Acerbi F
    Adv Exp Med Biol; 2023; 1405():377-403. PubMed ID: 37452946
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prolonged hypoxia alleviates prolyl hydroxylation-mediated suppression of RIPK1 to promote necroptosis and inflammation.
    Zhang T; Xu D; Liu J; Wang M; Duan LJ; Liu M; Meng H; Zhuang Y; Wang H; Wang Y; Lv M; Zhang Z; Hu J; Shi L; Guo R; Xie X; Liu H; Erickson E; Wang Y; Yu W; Dang F; Guan D; Jiang C; Dai X; Inuzuka H; Yan P; Wang J; Babuta M; Lian G; Tu Z; Miao J; Szabo G; Fong GH; Karnoub AE; Lee YR; Pan L; Kaelin WG; Yuan J; Wei W
    Nat Cell Biol; 2023 Jul; 25(7):950-962. PubMed ID: 37400498
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Anti-apoptotic protein BCL-XL as a therapeutic vulnerability in gastric cancer.
    Wei Y; Zhang L; Wang C; Li Z; Luo M; Xie G; Yang X; Li M; Ren S; Zhao D; Gao R; Gong JN
    Animal Model Exp Med; 2023 Jun; 6(3):245-254. PubMed ID: 37271936
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Predictive ability of pancreatic cyst fluid biomarkers: A systematic review and meta-analysis.
    Pflüger MJ; Jamouss KT; Afghani E; Lim SJ; Rodriguez Franco S; Mayo H; Spann M; Wang H; Singhi A; Lennon AM; Wood LD
    Pancreatology; 2023 Nov; 23(7):868-877. PubMed ID: 37230894
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma.
    Mohl DA; Lagies S; Zodel K; Zumkeller M; Peighambari A; Ganner A; Plattner DA; Neumann-Haefelin E; Adlesic M; Frew IJ; Kammerer B
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190010
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genotype-phenotype correlations and clinical outcomes of patients with von Hippel-Lindau disease with large deletions.
    Zhang K; Yang W; Ma K; Qiu J; Li L; Xu Y; Zhang Z; Yu C; Zhou J; Gong Y; Cai L; Gong K
    J Med Genet; 2023 May; 60(5):477-483. PubMed ID: 37080588
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Targeting of SOS1: from SOS1 Activators to Proteolysis Targeting Chimeras.
    Hamilton G; Stickler S; Rath B
    Curr Pharm Des; 2023; 29(22):1741-1746. PubMed ID: 37073657
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
    Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP
    Semin Oncol; 2022 Dec; 49(6):476-481. PubMed ID: 36759234
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The road to systemic therapy in von Hippel-Lindau (vhl) disease: Are we there yet?
    Shepherd STC; Drake WM; Turajlic S
    Eur J Cancer; 2023 Mar; 182():15-22. PubMed ID: 36708612
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Belzutifan (MK-6482): Biology and Clinical Development in Solid Tumors.
    Choi WW; Boland JL; Kalola A; Lin J
    Curr Oncol Rep; 2023 Feb; 25(2):123-129. PubMed ID: 36630072
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comprehensive characterization and building of National Registry of von Hippel-Lindau disease in Brazil.
    Dallagnol TN; Da Cás E; Junior OR; Casali-da-Rocha JC
    Mol Genet Genomic Med; 2023 Apr; 11(4):e2136. PubMed ID: 36625343
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 16.